PubMed ID,Title,Publication Date,Pharma/Biotech Author(s),Company Affiliation(s),Corresponding Author(s) Email
40079180,"Design, synthesis and biological evaluation of pyrazolo[3,4-",2025,"Mahmoud S Elkotamy, Mohamed K Elgohary, Faizah A Binjubair, Manal M Alanazi, Marwa Alsulaimany, Sara T Al-Rashood","Pharmaceutical Chemistry Department, Faculty of Pharmacy, Egyptian-Russian University, Badr City, Egypt., Pharmaceutical Chemistry Department, Faculty of Pharmacy, Egyptian-Russian University, Badr City, Egypt., Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia., Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia., Department of Pharmacognosy and Pharmaceutical Chemistry, College of Pharmacy, Taibah University, Medina, Saudi Arabia., Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.",N/A
40079105,Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial.,2025,"James Hanyok, Li Liu, Yasser Mostafa Kamel, Karima Imadalou, Arnaud Lesegretain","Daiichi Sankyo, Inc, Basking Ridge, NJ., Daiichi Sankyo, Inc, Basking Ridge, NJ., Daiichi Sankyo, Inc, Basking Ridge, NJ., Daiichi Sankyo, Inc, Basking Ridge, NJ., Daiichi Sankyo, Inc, Basking Ridge, NJ.",N/A
40078999,Maplirpacept: a CD47 decoy receptor with minimal red blood cell binding and robust anti-tumor efficacy.,2025,"Mithunah Krishnamoorthy, Ruth Seelige, Christopher R Brown, Nancy Chau, Natasja Nielsen Viller, Lisa D S Johnson, Emma Linderoth, Christopher P Dillon, Keith Abayasiriwardana, Clare Lees, Mark Wong, Megan M Kaneda, Robert A Uger, Gloria H Y Lin","Pfizer Oncology, Pfizer Inc., La Jolla, CA, United States., Pfizer Oncology, Pfizer Inc., La Jolla, CA, United States., Pfizer Oncology, Pfizer Inc., La Jolla, CA, United States., Pfizer Oncology, Pfizer Inc., La Jolla, CA, United States., Research and Development, Trillium Therapeutics Inc., Mississauga, ON, Canada., Research and Development, Trillium Therapeutics Inc., Mississauga, ON, Canada., Research and Development, Trillium Therapeutics Inc., Mississauga, ON, Canada., Pfizer Oncology, Pfizer Inc., La Jolla, CA, United States., Pfizer Oncology, Pfizer Inc., La Jolla, CA, United States., Pfizer Oncology, Pfizer Inc., La Jolla, CA, United States., Research and Development, Trillium Therapeutics Inc., Mississauga, ON, Canada., Pfizer Oncology, Pfizer Inc., La Jolla, CA, United States., Research and Development, Trillium Therapeutics Inc., Mississauga, ON, Canada., Pfizer Oncology, Pfizer Inc., La Jolla, CA, United States.",N/A
40078964,Profiling hippocampal neuronal populations reveals unique gene expression mosaics reflective of connectivity-based degeneration in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.,2025,Grace E Stutzmann,"Center for Neurodegenerative Disease and Therapeutics, Rosalind Franklin University, The Chicago Medical School, North Chicago, IL, United States.",N/A
40078787,Regulation of Ferroptosis in Cancer and Immune Cells.,2025,"Naeyoon Jang, Il-Kyu Kim, Dawoon Jung, Yeonseok Chung, Yun Pyo Kang","College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Korea., College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Korea., College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Korea., College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Korea., College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Korea.",N/A
